ClinicalTrials.Veeva

Menu

RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

I

Istituto Clinico Humanitas

Status

Completed

Conditions

GnRH Trigger and Rescue Protocol

Treatments

Drug: GnRH agonist

Study type

Observational

Funder types

Other

Identifiers

NCT03837223
trigger

Details and patient eligibility

About

Ovarian Hyperstimulation Syndrome (OHSS) is one of the most dangerous complications of Assisted Reproductive Technologies (ART) cycles. The use in clinical practice of the GnRH antagonist has made it possible to perform the trigger with GnRH analogues reducing the risk of OHSS. The trigger with analogue increases the Abortion Rate (AR) and reduces the Ongoing Pregnancy Rate (OPR), because the luteal phase in these cycles is particularly deficient. To reduce this occurrence several studies have focused on the importance of support of the luteal phase. The aims of study is to evaluate OPR and AR in patients at intermediate risk of OHSS (<18 recovered oocytes) which performed GnRH trigger and rescue protocol.

Enrollment

271 patients

Sex

Female

Ages

18 to 38 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

AMH ( antimullerian hormone) > 3.5 ng / ml, AFC (antral follicles count) > 15 follicles and if more than 18 follicles with diam. 12mm to induction

Exclusion criteria

high risk of OHSS ( ovarian hyperstimulation syndrome)

Trial design

271 participants in 1 patient group

patients underwent "rescue protocols" and fresh embryotransfer
Description:
they were patients with good prognosis with a mean age of 34.13 ± 4.42 years, with a good ovarian reserve
Treatment:
Drug: GnRH agonist

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems